R2P Radifocus Glidewire Advantage
K-Number: K240818 · 2024-11-26
Device Summary
Frequently Asked Questions
What is the R2P Radifocus Glidewire Advantage?
R2P Radifocus Glidewire Advantage is a medical device that received FDA 510(k) clearance on 2024-11-26. The listed applicant is Terumo Corporation. The 510(k) number is K240818.
When did R2P Radifocus Glidewire Advantage receive FDA 510(k) clearance?
R2P Radifocus Glidewire Advantage received FDA 510(k) clearance on 2024-11-26, under 510(k) number K240818.
Who is the listed applicant for R2P Radifocus Glidewire Advantage?
The FDA 510(k) record lists Terumo Corporation as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for R2P Radifocus Glidewire Advantage?
The FDA product code for R2P Radifocus Glidewire Advantage is DQX.
Other records listing Terumo Corporation as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: DQX)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.